PharmaShots | Incisive News in 3 Shots

Subscribe Now

PeproMene Bio

PeproMene Bio Reports Results from the P-I Study of PMB-CT01 for the Treatment of R/R B-Cell Acute Lymphoblastic Leukemia

PeproMene Bio Reports Results from the P-I Study of PMB-CT01 for the Treatment of R/R B-Cell Acute Lymphoblastic Leukemia

January 18, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us